441 related articles for article (PubMed ID: 16484711)
1. Targeting angiogenesis with integrative cancer therapies.
Yance DR; Sagar SM
Integr Cancer Ther; 2006 Mar; 5(1):9-29. PubMed ID: 16484711
[TBL] [Abstract][Full Text] [Related]
2. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2.
Sagar SM; Yance D; Wong RK
Curr Oncol; 2006 Jun; 13(3):99-107. PubMed ID: 17576449
[TBL] [Abstract][Full Text] [Related]
3. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1.
Sagar SM; Yance D; Wong RK
Curr Oncol; 2006 Feb; 13(1):14-26. PubMed ID: 17576437
[TBL] [Abstract][Full Text] [Related]
4. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
McCarty MF
Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106
[TBL] [Abstract][Full Text] [Related]
5. Targeting angiogenesis in head and neck cancer.
Seiwert TY; Cohen EE
Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis in cancer patients.
Verheul HM; Pinedo HM
Expert Opin Emerg Drugs; 2005 May; 10(2):403-12. PubMed ID: 15934875
[TBL] [Abstract][Full Text] [Related]
7. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
Wagner AD; Moehler M
Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis and gliomas: current issues and development of surrogate markers.
Jouanneau E
Neurosurgery; 2008 Jan; 62(1):31-50; discussion 50-2. PubMed ID: 18300890
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibitors in cancer therapy.
Dredge K; Dalgleish AG; Marriott JB
Curr Opin Investig Drugs; 2003 Jun; 4(6):667-74. PubMed ID: 12901224
[TBL] [Abstract][Full Text] [Related]
10. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment.
Gagne P; Akalu A; Brooks PC
Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663
[TBL] [Abstract][Full Text] [Related]
11. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity.
Prasad KN
Integr Cancer Ther; 2004 Dec; 3(4):310-22. PubMed ID: 15523102
[TBL] [Abstract][Full Text] [Related]
12. The combination of antiangiogenic therapy with other modalities.
O'Reilly MS
Cancer J; 2002; 8 Suppl 1():S89-99. PubMed ID: 12075706
[TBL] [Abstract][Full Text] [Related]
13. Current development status of small-molecule vascular disrupting agents.
Chaplin DJ; Horsman MR; Siemann DW
Curr Opin Investig Drugs; 2006 Jun; 7(6):522-8. PubMed ID: 16784022
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenesis: the fifth cancer treatment modality?
Camp-Sorrell D
Oncol Nurs Forum; 2003; 30(6):934-44. PubMed ID: 14603351
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
Cao Y
Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic phytochemicals and medicinal herbs.
Jeong SJ; Koh W; Lee EO; Lee HJ; Lee HJ; Bae H; Lü J; Kim SH
Phytother Res; 2011 Jan; 25(1):1-10. PubMed ID: 20564543
[TBL] [Abstract][Full Text] [Related]
17. Novel angiogenesis inhibitors: addressing the issue of redundancy in the angiogenic signaling pathway.
Ribatti D
Cancer Treat Rev; 2011 Aug; 37(5):344-52. PubMed ID: 21435792
[TBL] [Abstract][Full Text] [Related]
18. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
Plavetić ND; Letilović T; Vrbanec D
Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
[TBL] [Abstract][Full Text] [Related]
19. Combining radiotherapy and angiogenesis inhibitors: clinical trial design.
Citrin D; Ménard C; Camphausen K
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):15-25. PubMed ID: 16377411
[TBL] [Abstract][Full Text] [Related]
20. Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.
Le Tourneau C; Vidal L; Siu LL
Drug Resist Updat; 2008 Jun; 11(3):99-109. PubMed ID: 18515176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]